Usefulness of the 2012 European CVD risk assessment model to identify patients at high risk of cardiovascular events during nilotinib therapy in chronic myeloid leukemia.
作者信息
Rea D, Mirault T, Raffoux E, Boissel N, Andreoli A L, Rousselot P, Dombret H, Messas E
机构信息
Hématologie Adulte, Hôpital Saint-Louis, AP-HP, Paris, France.
1] Médecine vasculaire, Hôpital européen Georges Pompidou, AP-HP, Paris, France [2] INSERM UMR970, PARCC, Paris Descartes University, Sorbonne Paris Cité, Paris, France.
出版信息
Leukemia. 2015 May;29(5):1206-9. doi: 10.1038/leu.2014.342. Epub 2014 Dec 8.
PMID:25482133
Abstract
摘要
Zotero 插件